Autonomix Medical, Inc. Common Stock (AMIX) - Total Assets
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) holds total assets worth $7.60 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See debt-free asset ratio of Autonomix Medical, Inc. Common Stock to measure how much of total assets are equity-financed.
Autonomix Medical, Inc. Common Stock - Total Assets Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. Check AMIX operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Autonomix Medical, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (March 2026)
Autonomix Medical, Inc. Common Stock's total assets of $7.60 Million consist of 99.8% current assets and 0.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 92.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Autonomix Medical, Inc. Common Stock.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Autonomix Medical, Inc. Common Stock's current assets represent 99.8% of total assets in 2026, a decrease from 100.0% in 2022.
- Cash Position: Cash and equivalents constituted 92.2% of total assets in 2026, down from 99.6% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Autonomix Medical, Inc. Common Stock Competitors by Total Assets
Key competitors of Autonomix Medical, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $911.38 Million |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
Scandinavian Medical Solutions AS
CO:SMSMED
|
Denmark | Dkr205.86 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr10.84 Million |
Autonomix Medical, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.45 | 5.63 | 3.91 |
| Quick Ratio | 4.45 | 5.63 | 3.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.88 Million | $7.90 Million | $644.00K |
Autonomix Medical, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Autonomix Medical, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.78 |
| Latest Market Cap to Assets Ratio | 0.55 |
| Asset Growth Rate (YoY) | -22.5% |
| Total Assets | $7.60 Million |
| Market Capitalization | $4.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Autonomix Medical, Inc. Common Stock's assets below their book value (0.55x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Autonomix Medical, Inc. Common Stock's assets decreased by 22.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual total assets of Autonomix Medical, Inc. Common Stock from 2022 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | $7.60 Million | -22.50% |
| 2025-03-31 | $9.81 Million | +4.24% |
| 2024-03-31 | $9.41 Million | +987.51% |
| 2023-03-31 | $865.00K | -57.86% |
| 2022-03-31 | $2.05 Million | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresse… Read more